Angela Sarna

BACKGROUND: The majority of HCC patients within Milan criteria, compete with cirrhosis patients with high MELD for liver transplantation based on an exceptional score which is the calculated MELD at registration, 28 after six months of waiting, 31 after 1 year and thereafter capped at 34 after one…

Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…

Objectives: Neoadjuvant therapy (NT) is increasingly utilized prior to surgery for most gastrointestinal (GI) and hepatopancreatobiliary (HPB) malignancies. However, chemotherapy and radiation therapy can cause significant symptoms and a high incidence of adverse events…